AS

Arti Saroha

Active Director Director DIN 09465671
DIN 09465671 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Arti Saroha

Data last updated:

Arti Saroha is a Director at Ado Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Ado Pharmaceuticals Private Limited reported revenue of ₹19.1 Lakh (FY 2024).

DIN 09465671
Primary Designation Director
Industry Chemicals
First Appointment 09 Feb 2022
Oldest Company Age 4 yrs
Largest company Ado Pharmaceuticals Private Limited · ₹19.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ado Pharmaceuticals Private Limited U24290PB2022PTC055199
Director09 Feb 20222022₹19.1 Lakh (FY 2024)Active

Board colleagues of Arti Saroha

NameDINCompanyDesignation
Arun Singh09465447Ado Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ado Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arti Saroha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arti Saroha

Arti Saroha currently holds 1 directorship: Ado Pharmaceuticals Private Limited (Director, since 09 Feb 2022, revenue ₹19.1 Lakh (FY 2024)).

Arti Saroha was first appointed on 09 Feb 2022 as Director at Ado Pharmaceuticals Private Limited.

The current boards of Arti Saroha's companies include Arun Singh (Ado Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available